BIB241220C66000
- 1.18
- 0.000.00%
Ultra Nasdaq Biotechnology Proshares Newsroom
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
Amneal Gets FDA Approval for Generic Byetta, Resubmits DHE NDA
Optimism Over Global Healthcare Sector Rises: Jefferies
AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
Gilead Sciences Analyst Ratings
Biogen Analyst Ratings
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
CDC Warns Against a Spike in COVID, Flu Cases
Decoding Amgen's Options Activity: What's the Big Picture?
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
U.S. CDC Says Flu, Covid-19, RSV Illnesses Are At Low Levels Right Now Overall In U.S., But We Expect Them To Increase In Coming Weeks; Expects Hospitalizations For Flu And Covid-19 To Start Increasing In Coming Weeks
Tectonic Started at Outperform by Raymond James, TX45 Cited
This AstraZeneca Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
AstraZeneca Analyst Ratings
US pharmaceutical stocks plummet, has the market overreacted to Little Kennedy?
Source: Analysis from Wall Street News states that even if Kennedy is confirmed as the Secretary of Health in the usa, he may not be able to "make a big impact". First, there may be divisions within Trump's team; secondly, it is uncertain whether Kennedy has the authority to appoint leaders of departments like the FDA; finally, Trump may appoint individuals with industry backgrounds as FDA commissioners, directing Kennedy's attention to focus on nutrition rather than pharmaceutical approvals. The famous "anti-vaccine pioneer" and advocate for healthy eating, the new government-nominated Secretary of Health Robert Kennedy, is dining with the loyal "fast food enthusiast" Trump, who promotes rapid vaccine development.
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst